Partner Content Partner Content Boehringer Ingelheim to present data at RAS Summit Europe RAS- Targeted Drug Discovery Europe Conference
Events Partner Content 4th Annual PREDiCT Tumor Models San Francisco Serving the immuno-oncology scientific community
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
